PI3Kα in the pathogenesis and treatment of lupus nephritis.

Kasinath, V., & Tsokos, G. C. (2024). PI3Kα in the pathogenesis and treatment of lupus nephritis.. Kidney International.

Publisher's Version

Last updated on 12/09/2024
PubMed

Recent Publications

The emergence of SLE-causing UNC93B1 variants in 2024.
Estimation of prevalence of autoimmune diseases in the United States using electronic health record data.
The Role of Podocytes in Lupus Pathology.
Expanded CD8+CD38+ T Cell Population in Patients With Systemic Lupus Erythematosus Is Linked to Increased Infection Rates: A Prospective Study.
Hypoxia Promotes the Expression of ADAM9 by Tubular Epithelial Cells, Which Enhances Transforming Growth Factor β1 Activation and Promotes Tissue Fibrosis in Patients With Lupus Nephritis.
CD38 in SLE CD4 T cells promotes Ca2+ flux and suppresses interleukin-2 production by enhancing the expression of GM2 on the surface membrane.

george-tsokos

Twitter

Tsokos lab has focused on the cellular and molecular pathogenesis of systemic lupus erythematosus (SLE). Our laboratory has opened and led the field of molecular abnormalities on immune cells in patients with SLE.

Secondary menu

About
Research
News

Powered byOpenScholar^®Admin Login